To further examine the disease-relevant role of NMNAT in glioma growth, we analyzed patient data from the Cancer Genome Atlas (TCGA) to determine how NMNAT expression levels affect survival in glioma and glioblastoma, using the gene expression profiling interactive platform, GEPIA (http://gepia.cancer- pku.cn/). This evidence concerns the gene NMNAT1 and glioblastoma.